特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
935813

ビタミンK2市場 - 市場シェア、規模、動向、業界分析:2020年~2026年

Vitamin K2 Market Share, Size, Trends, Industry Analysis Report By Source (Synthetic, Natural); By Product; By Application; By Regions, Segments & Forecast, 2020 - 2026

出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
ビタミンK2市場 - 市場シェア、規模、動向、業界分析:2020年~2026年
出版日: 2020年04月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のビタミンK2市場規模は、2026年までに2億9030万米ドルに達すると予測されています。

当レポートでは、世界のビタミンK2市場について調査分析し、市場概要、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 概要と範囲

第2章 エグゼクティブサマリー

第3章 調査手法

第3章 ビタミンK2市場の考察

  • ビタミンK2:業界スナップショット
  • ビタミンK2:エコシステム分析
  • ビタミンK2市場力学
  • 業界分析-:ファイブフォース分析
  • ビタミンK2市場のPEST分析
  • バリューチェーン分析
  • ビタミンK2業界の動向
  • 競合ランキング分析
  • 消費者の購買行動

第4章 ビタミンK2市場規模と予測:由来別

  • 製品別
  • 天然
  • 合成

第5章 ビタミンK2市場規模と予測:製品別

  • 製品別
  • MK-4
  • MK-7
  • その他

第6章 ビタミンK2市場規模と予測:用途別

  • 用途別
  • 医薬品
  • 栄養補助食品、食品
  • その他

第7章 ビタミンK2市場規模と予測:地域別

  • 地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

目次
Product Code: PM1669

The global Vitamin K2 market size is expected to reach USD 290.3 million by 2026 according to a new study by Polaris Market Research. The report "Vitamin K2 Market Share, Size, Trends, Industry Analysis Report By Product (MK-4, and MK-7), By Application (Pharmaceuticals, Nutraceuticals & Food, Others); By Source (Natural, Synthetic, Others); By Regions, Segment Forecast, 2020 - 2026" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The alarming cases of vitamin deficiency in humans are anticipated to be a primary trigger for demand in the global market. A study conducted by the Food & Agriculture Organization of United Nations (FAO) in the year 2018 revealed that vitamin K deficiency bleeding (VKDB) in infants has emerged to be a major concern for infant mortality. Such incidences are anticipated to be the primary demand generators over the forecast period.

Osteoporosis is another major ailment which constraints growth of new tissues in the human body. More than 38 million people globally suffered of osteoporosis between 2017-18, as per Osteoporosis Foundation statistics. Hence, compensation of calcium deficiency in the human body is expected to be the main area of vitamin K2 consumption. Multifunctional ingredients ensure extended shelf life of foods, and significantly improve the texture and taste of the end-products, hence these ingredients have become a rage in the pharmaceutical industry. The ageing as well as geriatric population creates a bigger room for manufacturers in terms of product innovation.

As far as the production/derivation methods of vitamin K2 are concerned, natural source accounts for a higher share in the market followed by synthetic means. Production method of the ingredient is a crucial concern particularly in the pharmaceutical industry, as manufacturers have to keenly assess the drug testing criteria put forth by governing authorities. The pharmaceuticals and food application segment is expected to consume the highest amount of vitamin K2 as a result of changing lifestyles, health awareness, and rising disposable income of people. Powders and oils are the primary forms through which vitamin K2 would be integrated in foods.

As of 2019, North America holds the largest market share followed by Europe and Asia Pacific. A drastic increase in the consumption of functional foods by the citizens of Australia, China, and India are likely to speed up the demand of vitamin K2 in Asia Pacific over the next five years. Middle East and Africa is likely to pose a moderate demand for vitamin K2 because of the already existing health and wellness campaigns deployed by the government.

Mergers & acquisitions (M&A), collaborations, partnerships, capacity expansion plans, heavy amount of research & development, and signing long term distribution contracts with local sales giants are the key strategies adhered by market participants to maintain and strengthen their position in the global landscape.

The key players in the market include Danisco A/S (DuPont Health and Nutrition), Kappa Bioscience, DSM, BASF, Gnosis SpA, Frutarom, NattoPharma, Seebio Biotech, and Geneferm Biotechnology Co. Ltd. among others. Direct selling proves to be a cost-effective channel for SMEs to gain customer trust.

Polaris Market research has segmented the vitamin K2 market report on the basis of product, application, source and region

Vitamin K2 Product Outlook (Revenue, USD Million, 2015 - 2026)

MK-4

MK-7

Others

Vitamin K2 Application Outlook (Revenue, USD Million, 2015 - 2026)

Pharmaceutical

Nutraceuticals & Food

Others

Vitamin K2 Source Outlook (Revenue, USD Million, 2015 - 2026)

Natural

Synthetic

Vitamin K2 Regional Outlook (Revenue, USD Million, 2015 - 2026)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Russia

Asia Pacific

China

India

Japan

Korea

Latin America

Mexico

Brazil

Colombia

Middle East & Africa

Saudi Arabia

Israel

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-aways
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Vitamin K2 Market Insights

  • 3.1. Vitamin K2 - Industry snapshot
  • 3.2. Vitamin K2 - Ecosystem analysis
  • 3.3. Vitamin K2 market dynamics
    • 3.3.1. Vitamin K2 - Market Forces
      • 3.3.1.1. Vitamin K2 Market driver analysis
      • 3.3.1.2. Vitamin K2 Market restraint/challenges analysis
      • 3.3.1.3. Vitamin K2 Market opportunity analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Vitamin K2 market PEST analysis
  • 3.6. Value Chain Analysis
  • 3.7. Vitamin K2 Industry trends
  • 3.8. Competitive Ranking Analysis, 2019
  • 3.9. Consumer Buying Behavior

4. Vitamin K2 Market Size and Forecast by Source

  • 4.1. Global Vitamin K2 market share by Product, 2020 & 2026
  • 4.2. Natural
    • 4.2.1. Global natural Vitamin K2 market estimates and forecasts, 2015 - 2026 (USD Million)
    • 4.2.2. Global natural Vitamin K2 market estimates and forecasts, by region, 2015 - 2026 (USD Million)
  • 4.3. Synthetic
    • 4.3.1. Global synthetic Vitamin K2 market estimates and forecasts, 2015 - 2026 (USD Million)
    • 4.3.2. Global synthetic Vitamin K2 market estimates and forecasts, by region, 2015 - 2026 (USD Million)

5. Vitamin K2 Market Size and Forecast by Product

  • 5.1. Global Vitamin K2 market share by Product, 2020 & 2026
  • 5.2. MK-4
    • 5.2.1. Global MK-4 Vitamin K2 market estimates and forecasts, 2015 - 2026 (USD Million)
    • 5.2.2. Global MK-4 Vitamin K2 market estimates and forecasts, by region, 2015 - 2026 (USD Million)
  • 5.3. MK-7
    • 5.3.1. Global MK-7 Vitamin K2 market estimates and forecasts, 2015 - 2026 (USD Million)
    • 5.3.2. Global MK-7 Vitamin K2 market estimates and forecasts, by region, 2015 - 2026 (USD Million)
  • 5.4. Others
    • 5.4.1. Global others Vitamin K2 market estimates and forecasts, 2015 - 2026 (USD Million)
    • 5.4.2. Global others Vitamin K2 market estimates and forecasts, by region, 2015 - 2026 (USD Million)

6. Vitamin K2 Market Size and Forecast by Application

  • 6.1. Global Vitamin K2 market share by Application, 2020 & 2026
  • 6.2. Pharmaceutical
    • 6.2.1. Global Vitamin K2 in pharmaceutical market estimates and forecasts, 2015 - 2026 (USD Million)
    • 6.2.2. Global Vitamin K2 in pharmaceutical market estimates and forecasts, by region, 2015 - 2026 (USD Million)
  • 6.3. Nutraceuticals & Food
    • 6.3.1. Global Vitamin K2 in nutraceuticals & food market estimates and forecasts, 2015 - 2026 (USD Million)
    • 6.3.2. Global Vitamin K2 in nutraceuticals & food market estimates and forecasts, by region, 2015 - 2026 (USD Million)
  • 6.4. Others
    • 6.4.1. Global Vitamin K2 in others market estimates and forecasts, 2015 - 2026 (USD Million)
    • 6.4.2. Global Vitamin K2 in others market estimates and forecasts, by region, 2015 - 2026 (USD Million)

7. Vitamin K2 Market Size and Forecast by Regions

  • 7.1. Global Vitamin K2 market share by region, 2020 & 2026
  • 7.2. North America
    • 7.2.1. North America Vitamin K2 market by product (USD Million), 2015 - 2026
    • 7.2.2. North America Vitamin K2 market by application (USD Million), 2015 - 2026
    • 7.2.3. North America Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.2.4. U.S.
      • 7.2.4.1. U.S. Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.2.4.2. U.S. Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.2.4.3. U.S. Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.2.5. Canada
      • 7.2.5.1. Canada Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.2.5.2. Canada Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.2.5.3. Canada Vitamin K2 market by source (USD Million), 2015 - 2026
  • 7.3. Europe
    • 7.3.1. Europe Vitamin K2 market by product (USD Million), 2015 - 2026
    • 7.3.2. Europe Vitamin K2 market by application (USD Million), 2015 - 2026
    • 7.3.3. Europe Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.3.4. Germany
      • 7.3.4.1. Germany Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.3.4.2. Germany Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.3.4.3. Germany Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.3.5. UK
      • 7.3.5.1. UK Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.3.5.2. UK Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.3.5.3. UK Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.3.6. France
      • 7.3.6.1. France Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.3.6.2. France Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.3.6.3. France Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.3.7. Italy
      • 7.3.7.1. Italy Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.3.7.2. Italy Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.3.7.3. Italy Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.3.8. Russia
      • 7.3.8.1. Russia Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.3.8.2. Russia Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.3.8.3. Russia Vitamin K2 market by source (USD Million), 2015 - 2026
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Vitamin K2 market by product (USD Million), 2015 - 2026
    • 7.4.2. Asia Pacific Vitamin K2 market by application (USD Million), 2015 - 2026
    • 7.4.3. Asia Pacific Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.4.4. China
      • 7.4.4.1. China Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.4.4.2. China Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.4.4.3. China Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.4.5. India
      • 7.4.5.1. India Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.4.5.2. India Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.4.5.3. India Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.4.6. Japan
      • 7.4.6.1. Japan Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.4.6.2. Japan Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.4.6.3. Japan Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.4.7. South Korea
      • 7.4.7.1. South Korea Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.4.7.2. South Korea Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.4.7.3. South Korea Vitamin K2 market by source (USD Million), 2015 - 2026
  • 7.5. Latin America
    • 7.5.1. Latin America Vitamin K2 market by product (USD Million), 2015 - 2026
    • 7.5.2. Latin America Vitamin K2 market by application (USD Million), 2015 - 2026
    • 7.5.3. Latin America Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.5.4. Brazil
      • 7.5.4.1. Brazil Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.5.4.2. Brazil Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.5.4.3. Brazil Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.5.5. Mexico
      • 7.5.5.1. Mexico Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.5.5.2. Mexico Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.5.5.3. Mexico Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.5.6. Colombia
      • 7.5.6.1. Colombia Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.5.6.2. Colombia Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.5.6.3. Colombia Vitamin K2 market by source (USD Million), 2015 - 2026
  • 7.6. Middle East & Africa
    • 7.6.1. MEA Vitamin K2 market by product (USD Million), 2015 - 2026
    • 7.6.2. MEA Vitamin K2 market by application (USD Million), 2015 - 2026
    • 7.6.3. MEA Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Saudi Arabia Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.6.4.2. Saudi Arabia Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.6.4.3. Saudi Arabia Vitamin K2 market by source (USD Million), 2015 - 2026
    • 7.6.5. Israel
      • 7.6.5.1. Israel Vitamin K2 market by product (USD Million), 2015 - 2026
      • 7.6.5.2. Israel Vitamin K2 market by application (USD Million), 2015 - 2026
      • 7.6.5.3. Israel Vitamin K2 market by source (USD Million), 2015 - 2026

8. Company Profiles

  • 8.1. Kappa Bioscience
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. DuPont Health and Nutrition
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. DSM
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Gnosis SpA
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. NattoPharma
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. Seebio Biotech
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Viridis BioPharma
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Frutarom
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Kyowa Hakko Bio Co. Ltd.
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. Geneferm Biotechnology Co. Ltd.
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.